Top broker says QBE (ASX:QBE) share price is a buy

This leading broker remains bullish on QBE…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The QBE Insurance Group Ltd (ASX: QBE) share price has been among the best performers on the ASX 200 in 2021.

Since the start of the year, the insurance giant's shares have risen just over 40%.

young woman reviewing financial reports at desk with multiple computer screens

Image Source: Getty Images

Can the QBE share price keep on rising?

The good news for shareholders is that one leading broker still believes the QBE share price can keep rising from here.

According to a recent note out of Goldman Sachs, its analysts have a conviction buy rating and $13.41 price target on its shares.

Based on the current QBE share price of $12.05, this implies potential upside of 11% over the next 12 months before dividends.

Furthermore, Goldman is forecasting partially franked dividends per share of 37 cents in FY 2021 and then 58 cents in FY 2022. This represents yields of 3.1% and 4.8%, respectively, over the two financial years.

What did the broker say?

Goldman was very pleased with QBE's performance during the first half of FY 2021 and notes that it delivered a result ahead of its expectations.

It commented: "QBE's 1H21 cash NPAT of US$467mn was 41% ahead of our US$330mn estimate. DPS of A11c was however below our A19c estimate (interim payout ratio of 27%) while the balance sheet remains in good shape, with the PCA ratio at 1.73x (GSe 1.70x) and gearing at 31.1%."

Overall, the broker believes its headline earnings are now representing underlying momentum. As a result, its analysts have upgraded their earnings estimates for the coming years.

It explained: "On balance, we upgrade our FY21-FY23 cash EPS by +13%/+5%/+3%, largely a function of reduced COVID costs and 1H releases in FY21, though stronger growth and margin in FY22/FY23."

"We note QBE formally flagged an intention to increase growth asset exposure in its investment portfolio over the medium term. With excess capital seemingly earmarked for growth currently, we have not yet modelled any re-weighting, though note a shift from the current 7% growth asset mix to the 15% ceiling at current FUM (and a 50bps running yield) would equate to a normalised annualised NPAT uplift of c.US$100m," it added.

All in all, the QBE share price may be smashing the market this year, but this leading broker believes it could continue doing so over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Broker Notes

A young man goes over his finances and investment portfolio at home.
Broker Notes

NextDC vs Wesfarmers shares: Which is a buy?

Analysts have given their verdict on these shares this week.

Read more »

Three smiling corporate people examine a model of a new building complex.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to buy these shares.

Read more »

Sell buy and hold on a digital screen with a man pointing at the sell square.
Broker Notes

Up 130% in a year, are Lynas Rare Earths shares still a good buy today?

Lynas Rare Earths shares have more than doubled ASX investors’ money in a year. Is there still time to buy?

Read more »

Woman chooses vegetables for dinner, smiling and looking at camera.
Broker Notes

3 reasons to buy Coles shares today

A leading analyst expects Coles shares are well-placed to outperform. But why?

Read more »

A businesswoman pulls her glasses down in shock to look at the bad news on her computer.
Broker Notes

Why did Morgans just lower its outlook on Collins Food and Pro Medicus shares?

Despite lowering its guidance, these stocks remain undervalued according to at least one expert.

Read more »

Business people discussing project on digital tablet.
Broker Notes

BHP vs Coles shares: Which is the better buy this week?

Let's see which one of these giants is being recommended as a buy by analysts.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Broker Notes

Brokers name 3 ASX shares to buy right now

Here's why brokers are feeling bullish about these three shares this week.

Read more »